Addiction

Article	Citations
Issue Information	159
Commentary on Borodovsky et al.: Enhancing research on THC quantification—Consumer awareness through accurate labelling	152
An Addiction series on regional perspectives on addiction‐related problems	137
	92
	88
Society for the Study of Addiction Annual Conference 2024	84
Nicotine strength of e‐liquids used by adult vapers in Great Britain: A population survey 2016 to 2024	83
Impulsivity behaviors and white matter mediate the relationship between genetic risk for cannabis use disorder and early cannabis use in adolescents	72
Commentary on Keyes and Patrick: Changes in psychedelic use in the United States may require changes in our narrative of psychedelic harms	70
National profile on substance use, substance use‐related problems and policy: The case of Chile	70
Does recreational cannabis legalization change cannabis use patterns? Evidence from secondary school students in Uruguay	68
Rare but relevant series	66
The use of financial incentives for smoking cessation in pregnant women: A parallel‐group randomised controlled trial protocol	65
Recent decline in Chinese alcohol production and consumption: Potential contributing factors and the role of globally recommended measures	64
Commentary on Stull et al.: Considering person‐specific heterogeneity when modeling time‐varying trends	64
Austin Bradford Hill’s ‘Environment and disease: Association or causation’	62
Cost‐effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO‐HCV trial	59
Will Australia's tightened prescription system reduce nicotine vaping among young people?	58
Education matters: longitudinal pathways to mid‐life heavy drinking in a national cohort of black Americans	56
Commentary on Nower et al: The Pathways Model should apply to non‐clinical gambling patterns	56
Cannabis: Global Histories by Lucas Richert and James H. Mills, editors	54
How substance use prevention research gets used in United States federal policy	52
Did the under‐reporting of meth/amphetamine use increase in a general population survey in Australia as negative media coverage increased?	46
Naloxone administration—no balance without titration	46
Quantifying alcohol‐attributable disability‐adjusted life years to others than the drinker in Aotearoa/New Zealand: A modelling study based on administrative data	45

Response to Hall et al.: Prescription psychostimulants for amphetamine‐type stimulant use disorder ‐ acknowledging challenges but not giving up on its potential cost‐effectiveness	45
Risk of readmission among individuals with cannabis use disorder during a 15‐year cohort study: the impact of socio‐economic factors and psychiatric comorbidity	43
Technology‐mediated just‐in‐time adaptive interventions (JITAIs) to reduce harmful substance use: a systematic review	42
Association of topiramate prescribed for any indication with reduced alcohol consumption in electronic health record data	42
Opioid overdose deaths and the expansion of opioid agonist treatment: a population‐based prospective cohort study	41
ABC‐training as a new intervention for hazardous alcohol drinking: Two proof‐of‐principle randomized pilot studies	41
Safety of ibogaine administration in detoxification of opioid‐dependent individuals: a descriptive open‐label observational study	41
Predictors of substance use during treatment for addiction: A network analysis of ecological momentary assessment data	41
Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population‐based, community intervention trial	40
Significant changes in preference of illicit drug use in a population of Hanoi, Vietnam—A 6‐year wastewater study (2018–2023)	40
Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial	39
Systematic review and meta‐analyses of cytisine to support tobacco cessation	37
Commentary on Lange et al.: Acute alcohol use before suicide—is it contributing to an increase in suicide rates in the United States?	35
Use of cessation products, e‐cigarettes and cigarette cessation outcomes among adults with substance use problems: Results from 2013–2021 (Waves 1–6) of the Population Assessment of Tobacco and Health	35
Estimating recent trends in alcohol sales in the United Kingdom from alcohol duty revenue	35
Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications	34
Non‐alcoholic beverage consumption among US adults who consume alcohol	34
New Books	32
Author Index	32
Age, period and cohort effects of heavy episodic drinking by sex/gender and socioeconomic position in Canada, 2000–2021	32
Assessing the impacts of alcohol outlets on crime as a natural experiment: agglomeration, churning and spatial effects	32
England's disposable vape ban: An inadequate solution to youth vaping with potential unintended consequences	32
	31
Issue Information	31
Evaluating the causal effect of tobacco smoking on white matter brain aging: a two‐sample Mendelian randomization analysis in UK Biobank	31
Opioid use disorder and the brain: a clinical perspective	30
Clinical alcohol guidelines are welcome—but upstream action is paramount	30
Impacts of recreational cannabis legalization on cannabis use: a longitudinal discordant twin study	29
Issue Information	29
	28
Commentary on Motschman et al.: Moving behavioral economic demand into the real world means moving beyond single schedules of reinforcement	27
How research and policy can shape driving under the influence of cannabis	27
Longitudinal trajectories of marijuana use in tobacco products among young adult Texas college students from 2015 to 2019	27
Neurophysiological error processing and addiction self‐awareness correlates of reduced insight in cannabis use disorder	27
Commentary on Luukkonen et al.: Policy possibilities for reducing public health harms related to pregnant people’s alcohol consumption	26
Commentary on Lannoy et al.: The continued value of within‐family designs in addiction and psychiatric research	26
Commentary on Amin‐Esmaeili et al.: Non‐abstinence outcomes in stimulant clinical trials—Why deny improvement?	25
Identifying and describing trajectories of alcohol use frequency and binge drinking frequency among those aged 15–30 years in a national cohort of US adolescents: A group‐based trajectory modeling app	25
Organ pathologies detected post‐mortem in patients receiving opioid agonist treatment for opioid use disorder: a nation‐wide 2‐year cross‐sectional study	25
Genetic support of a causal relationship between cannabis use and educational attainment: a two‐sample Mendelian randomization study of European ancestry	24
Reducing problematic alcohol use in employees: economic evaluation of guided and unguided web‐based interventions alongside a three‐arm randomized controlled trial	24
Age‐based differences in quantity and frequency of consumption when screening for harmful alcohol use	24
Commentary on Metcalfe et al.: ‘What works in AOD is when it feels like I am driving’ (Craig W, alcohol and drug peer worker)	24
Implications of the shift to DSM‐5 for alcohol use disorder prevalence estimates in the National Survey on Drug Use and Health	24
Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?	24
The cost and impact of distributing naloxone to people who are prescribed opioids to prevent opioid‐related deaths: findings from a modelling study	24
Risky alcohol consumption among women in Australia attending breast screening services: an exploratory cross‐sectional study	23
Perspectives on addiction‐related problems in India	23
Cannabis research in context: The case for measuring and embracing regional similarities and differences	22
Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: Challenges and opportunities	22

Obstetric pain management for pregnant women with opioid use disorder: A qualitative and quantitative comparison of patient and provider perspectives (QUEST study)	22
Influence of alcohol and acetaldehyde on cognitive function: findings from an alcohol clamp study in healthy young adults	22
A return on investment analysis for the 2017 increase in alcohol excise taxation in Lithuania	21
New Books	21
Drug Overdoses During the COVID‐19 Pandemic Among Recently Homeless Individuals	21
Estimating the impact of a police education program on hepatitis C virus transmission and disease burden among people who inject drugs in Tijuana, Mexico: A dynamic modeling analysis	21
Age–period–cohort analysis of past 12‐month cannabis use in Germany (1995–2021)	21
Deficits in general and smoking‐specific response inhibition in the Go/No‐Go task in individuals who smoke: A cross‐sectional analysis	21
Pain in people seeking and receiving opioid agonist treatment: A systematic review and meta‐analysis of prevalence and correlates	21
A comparative study of treatment retention in opioid use disorder: Subcutaneous injectable versus sublingual buprenorphine	21
	21
Effect of vaping on past‐year smoking cessation success of Australians in 2019—evidence from a national survey	20
	20
Commentary on Petrilliet al.: Assessing cannabis use in real‐world settings ‐ advances using standard THC units	20
Patient outcomes following buprenorphine treatment for opioid use disorder: A retrospective analysis of the influence of patient‐ and prescriber‐level characteristics in Massachusetts, USA	20
Issue Information	20
Non‐invasive brain stimulation for smoking cessation: a systematic review and meta‐analysis	20
Disentangling the contributions of alcohol use disorder and alcohol‐related liver disease towards dementia: A population‐based cohort study	20
	20
Issue Information	20
Evaluating the impact of vaping facts films on vaping harm perceptions among young adults in the UK: A randomized on‐line experiment	20
New perspectives on how to formulate alcohol drinking guidelines: Response to commentaries	20
Social genetic effects for drug use disorder among spouses	20
Issue Information	20
Prosecuting Poverty, Criminalizing Care. By WendyBach, Cambridge, UK: Cambridge University Press. 2022. ISBN: 9781108465533	19
Response to Luz & Mash on cardiac toxicity of ibogaine	19
Commentary on Schmidt et al.: Informed patient preference and prioritizing access to medications for opioid use disorder for pregnant individuals	19
Drugs, Identity and Stigma. By MichelleAddison, WilliamMcGovern & RuthMcGovern. Chan, Switzerland: Palgrave Macmillan, 2022. ISBN: 9783030982867	19
Combustible tobacco age‐of‐sale laws: an opportunity?	19
Commentary on Brothers et al.: The role of safer environment interventions in addressing injecting‐related bacterial and fungal infections	19
Nicotine pouch use by sex, school type and tobacco product use among Finnish adolescents during the 2023 change in regulatory scheme with deregulated sales	19
Response to Xiao et al.: If everything is a loot box, nothing is	18
Genome‐wide analysis reveals genetic overlap between alcohol use behaviours, schizophrenia and bipolar disorder and identifies novel shared risk loci	18
Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries	18
Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review	18
‘It's not what you'd term normal smoking’: a qualitative exploration of language used to describe heated tobacco product use and associated user identity	18
Fatal drug overdoses in healthcare workers: A thematic framework analysis of coroner reports	18
Changing patterns of nicotine product use and nicotine dependence among United States high‐school students: The National Youth Tobacco Survey, 2014–2023	18
Addiction Lives: Sir Ian Gilmore	18
The Opioid Epidemic in the United States: Missed Opportunities and Policy Failures. By Kant B.Patel & Mark E.Rushefsky, London, UK: Routledge, 2022. ISBN: 9781032105215	18
The interaction of e‐cigarette use and mental health symptoms on risk of cigarette smoking initiation among young adults in the United States	18
Systematic review of symptom‐level networks of alcohol use disorder	18
Sludge, dark patterns and dark nudges: A taxonomy of on‐line gambling platforms' deceptive design features	18
Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta‐analysis	18
Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type	17
Commentary on Jones et al.: We must consider emergency medical services data an opportunity for a view into a community	17
Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers	17
Daily associations between sleep and alcohol use among veterans: Acute and cumulative effects	17
Offering e‐cigarettes for smoking cessation and reduction in people with mental illness (ESCAPE): Protocol for a randomized controlled trial	17
Issue Information	17
Systematic review and meta‐analysis investigating nicotine, cotinine and carbon monoxide exposures in people who both smoke and use nicotine replacement therapy	17
Do internalising or externalising behaviours in adolescence mediate the child maltreatment‐alcohol substance use relationship?	17
Commentary on Craft et al.: Drug contaminants and substitutions in illicit vapes represent a major health risk	17
Should contingency management protocols and dissemination practices be modified to accommodate rising stimulant use and harm reduction frameworks?	17
Effect of a workplace mobile phone‐based instant messaging intervention on smoking cessation: a cluster‐randomized controlled trial	17
Addiction Lives: Robin Davidson	17
New Books	17
Challenges and opportunities for further research involving the cannabis‐to‐opioid use transition	16
How to interpret studies on the impact of legalizing cannabis	16
The advantages and downsides of online focus groups for conducting research on addictive online behaviours	16
Commentary on Yang et al.: The need for a renewed focus on identifying and responding to chronic pain among people with substance use disorders	16
Alcohol drinking, DNA methylation and psychiatric disorders: A multi‐omics Mendelian randomization study to investigate causal pathways	16
Rapid growth in disposable e‐cigarette vaping among young adults in Great Britain from 2021 to 2022: a repeat cross‐sectional survey	16
What policies the US Food and Drug Administration should pursue in response to the addiction and overdose crisis	16
Support for Aboriginal health services in reducing harms from alcohol: 2‐year service provision outcomes in a cluster randomized trial	16
Clinical management of withdrawal from benzodiazepine anxiolytic and hypnotic medications	16
Disparities in the receipt of alcohol brief intervention: The intersectionality of sex, age, and race/ethnicity	16
Issue Information	15
Rare but relevant: Hydrocarbons and sudden sniffing syndrome	15
The association between state cannabis policies and cannabis use among adults and youth, United States, 2002–2019	15
The price of a cigarette: 20 minutes of life?	15
New Books	15
Validating transdermal alcohol biosensors: a meta‐analysis of associations between blood/breath‐based measures and transdermal alcohol sensor output	15
Effects of interventions to combat tobacco addiction: Cochrane update of 2021 to 2023 reviews	15
Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID‐19 pandemic: An interrupted time‐series analysis in	15
	15
The efficacy of an internet‐based cognitive behavioral program added to treatment‐as‐usual for alcohol‐dependent patients in primary care: a randomized controlled trial	15
Functional connectivity in the central executive network predicts changes in binge drinking behavior during emerging adulthood: an observational prospective study	14
Prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018–2022	14
Risk of somatic disease and mortality in individuals of parents with alcohol use disorder: a register‐based cohort study	14

Issue Information	14
Cannabis use disorder and adverse cardiovascular outcomes: A population‐based retrospective cohort analysis of adults from Alberta, Canada	14
Association between change in alcohol use reported during routine healthcare screening and change in subsequent hospitalization: A retrospective cohort study	14
The geography of sobriety checkpoints and alcohol‐impaired driving	14
Yes, nitrous oxide addiction undeniably exists!	14
A response to ‘Association between punitive policies and neonatal abstinence syndrome among Medicaid‐insured infants in complex policy environments’	14
	14
Cost–utility analysis of provision of e‐cigarette starter kits for smoking cessation in emergency departments: An economic evaluation of a randomized controlled trial	14
Commentary on Jackson et al.: The role of regional tobacco control in centralised nations	14
Addressing the overdose crisis in North America with bold action	14
Effectiveness of an optimized text message and Internet intervention for smoking cessation: A randomized controlled trial	14
Better data access can lead to better collaborative conclusions: Results of a discussion with Heirene	14
Commentary on Murphy et al.: What will it take to prescribe extended‐release naltrexone to treat alcohol use disorder?	14
Using ecological momentary assessment to quantify Δ‐9‐tetrahydrocannabinol and cannabidiol use across different forms of cannabis: Feasibility in a sample of Canadian young adults reporting frequent c	14
Commentary on Sun and Tang: Measurement assessment and validity in problematic smartphone use	14
Issue Information	14
Evaluating the impact of minimum unit pricing for alcohol on road traffic accidents in Scotland after 20 months: An interrupted time series study	14
Packaging of disposable vaping products and e‐liquids in England, Canada and the United States: A content analysis	13
Stakeholders cannot simply wait for the gambling evidence‐base to develop: We must all help to build it	13
Issue Information	13
Harmful compared to what? The problem of gaming and ambiguous causal questions	13
Issue Information	13
Changes to our Editorial Team	13
Effect of perioperative high‐dose transdermal nicotine patch on pain sensitivity among male abstinent tobacco smokers undergoing abdominal surgery: A randomized controlled pilot study	13
A systematic review and meta‐analysis of factors associated with adolescent substance use in Africa, 2000 to 2020	13
Commentary on Lin et al.: The importance of valid reference standards in training supervised machine learning classifiers to detect alcohol misuse	13
Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug‐testing and law enforcement	13
Addiction Lives: Viv Evans	13
Cannabis policy bundles and traffic fatalities in the American States over time	13
Cannabis use and sleep problems among young adults by mental health status: A prospective cohort study	13
Decentering alcohol: Non‐drug pleasure and reinforcement as an alternative target	13
Mainstreaming smoking cessation brief advice in health systems using the United Nations human rights system	13
Referees	13
Issue Information	13
Within‐person associations of escalated electronic nicotine delivery systems use with cigarette, alcohol, marijuana and drug use behaviors among US young adults	13
Understanding successful policy innovation: The case of Portuguese drug policy	12
Deaths of despair	12
Population‐level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost‐effectiveness an	12
Mortality in the SuperMIX cohort of people who inject drugs in Melbourne, Australia: a prospective observational study	12
Prolonged diacetylmorphine take‐home during the COVID‐19 pandemic—Results of a retrospective cohort study	12
Understanding perceived addiction to and addictiveness of electronic cigarettes among electronic cigarette users: a cross‐sectional analysis of the International Tobacco Control Smoking and Vaping (IT	12
Post‐legalization shifts in cannabis use among young adults in Georgia—A nationally representative study	12
On the duration of cannabis effects and the presence of THC in the body	12
Classifying national drinking patterns in Europe between 2000 and 2019: A clustering approach using comparable exposure data	12
Is methamphetamine blood concentration in emergency department patients associated with the clinical picture?	12
Commentary on Hyland et al.: Digital treatment for alcohol use disorders ‐ challenges and opportunities	12
Development and evaluation of a risk algorithm predicting alcohol dependence after early onset of regular alcohol use	12
Standardised packs and larger health warnings: visual attention and perceptions among Colombian smokers and non‐smokers	12
Health impacts of a scale‐up of supervised injection services in a Canadian setting: an interrupted time series analysis	12
Evaluating the effectiveness of e‐cigarettes compared with usual care for smoking cessation when offered to smokers at homeless centres: protocol for a multi‐centre cluster‐randomized controlled trial	12
Alcohol use disorder criteria exhibit different comorbidity patterns	12
Commentary on Manthey et al.: No more missed opportunities—We need to address the absence of robust and comprehensive evaluations about the real‐world impact of statutory restrictions on alcoho	12
The impact of road safety policies in a deregulated alcohol tax environment in Hong Kong: a 15‐year time series analysis	12
Drunken snakes and sober owls: ancient authors on the relationship between animals and wine	12
	12
Efficacy of cannabidiol alone or in combination with Δ‐9‐tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence	12
The impacts of COVID‐19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia	12
Strategies to enhance the effects of pictorial warnings for cigarettes: results from a discrete choice experiment	12
Effect of 3 months and 12 months of financial incentives on 12‐month postpartum smoking cessation maintenance: A randomized controlled trial	12
Changing trends in drug overdose mortality in Spain, 2001–2022	12
The need to calibrate standardized cannabis measurements across cultures	12
Evaluation of statewide restrictions on e‐cigarette nicotine strength—United States, 2017–2022	12
Quantification of racial and ethnic disparities in alcohol‐related problems in light of different methodological approaches	12
Clinical management of psychostimulant withdrawal: review of the evidence	11
Comparison of strength and adulteration between illicit drugs obtained from cryptomarkets versus off‐line	11
How effective are remote and/or digital interventions as part of alcohol and drug treatment and recovery support? A systematic review and meta‐analysis	11
Extended‐release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review	11
When should we conduct large‐scale evaluations?	11
Evaluation of the effectiveness of cytisine for the treatment of smoking cessation: A systematic review and meta‐analysis	11
Amphetamine use and mental health difficulties across adolescence and young adulthood: An integrative data analysis of four Australasian cohort studies	11
How much does the absence of the ‘hidden population’ from United Kingdom household surveys underestimate smoking prevalence?	11
Let's talk about pleasure: Bridging the sociology and public health divide	11
E‐cigarette cessation and transitions in combusted tobacco smoking status: longitudinal findings from the US FDA PATH Study	11
Predicting severe alcohol use disorders in primary care using number of heavy drinking days	11
Within‐week associations between alcohol and other substance use and interaction with naltrexone among sexual and gender minority men in San Francisco, California, USA	11
Referees	11
Cannabis and sport: A World Anti‐Doping perspective	11
Issue Information	11
Electronic cigarettes and subsequent use of cigarettes in young people: An evidence and gap map	10
Quantity of delta‐9‐tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers	10
The risks of misclassifying addictive food substances as non‐addictive	10
Commentary on Edwards et al.: Alcohol use disorder—a different impact in young adulthood than later?	10
Will Australia's tightened prescription system reduce nicotine vaping among young people?	10
Socio‐economic inequalities in smoking and drinking in adolescence: Assessment of social network dynamics	10
Affected other interventions: a systematic review and meta‐analysis across addictions	10
Why it is important to conduct gambling research that is fair and free from conflicts of interest	10
Future Directions for the International Cannabis Toolkit (iCannToolkit)	10
Trends and projection in the proportion of (heavy) cannabis use in Germany from 1995 to 2021	10
Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta‐analysis of randomized controlled trials	10
Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study	10
Prenatal smoking, alcohol and caffeine exposure and offspring externalizing disorders: a systematic review and meta‐analysis	10
The environmental impact of tobacco products: Time to increase awareness and action	10
Predictors of alcohol and other drug treatment completion among young people accessing residential and community‐based treatment: A retrospective analysis of routinely collected service data	10
Use of disposable e‐cigarettes among youth who vape in Canada, England and the United States: Repeat cross‐sectional surveys, 2017–2023	10
Co‐action and changes in alcohol use during a smoking cessation attempt	10